In vitro models for the assessment of inflammatory and immuno-modulatory effects of the volatile organic compound chlorobenzene

Experimental and Toxicologic Pathology

Volumn 60, Issue 2-3, 2008, Pages 185-193

  Lehmann, Irina ^a   Röder Stolinski, Carmen ^a   Nieber, Karen ^b   Fischäder, Gundula ^a  

^a HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Chlorobenzene; In vitro; Inflammation; Interleukin 13; Lung epithelial cells; MCP 1; PBMC; Sealed exposure system; VOC

Indexed keywords

CHEMOKINE; CHLOROBENZENE; INTERLEUKIN 13; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; VOLATILE AGENT; VOLATILE ORGANIC COMPOUND;

ALLERGIC REACTION; ALLERGY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG TOXICITY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIZATION;

ANTIBODIES, BLOCKING; CARCINOMA, NON-SMALL-CELL LUNG; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOKINE CCL2; CHLOROBENZENES; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; LUNG NEOPLASMS; RESPIRATORY MUCOSA; SOLVENTS; VOLATILIZATION;

EID: 44749087818     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2008.01.009     Document Type: Article

References (24)

1. BUA. Chlorbenzol. In: Herausgegeben vom Beratergremium für umweltrelevante Altstoffe (BUA), editor. BUA-Stoffbericht, vol. 54. Weinheim: Gesellschaft Deutscher Chemiker VHC Verlagsgesellschaft; 1991. p. 1-261.
2. Coleman C.A., Hull B.E., McDougal J.N., and Rogers J.V. The effect of m-xylene on cytotoxicity and cellular antioxidant status in rat dermal equivalents. Toxicol Lett 142 (2003) 133-142
3. Dalich G.M., and Larson R.E. Temporal and dose-response features of monochlorobenzene hepatotoxicity in rats. Fundam Appl Toxicol 5 (1985) 105-116
4. Deichmann W.B. Halogenated cyclic hydrocarbons. In: Clayton G.D., and Clayton F.E. (Eds). Patty's industrial hygiene and toxicology. 3rd revised ed. (1981), Wiley, NY, USA 3603-3684
5. EPA. Health effects criteria document for chlorobenzene. Final draft. US Environmental Protection Agency, Washington, DC, 600/88-90/99. National Technical Information Service, PB89-192116, USA; 1988.
6. EPA. Consumer factsheet on: CHLOROBENZENE. 〈http://www.epa.gov/safewater/dwh/c-voc/chlorobe.html〉; 2006.
7. Fischäder G., Röder-Stolinski C., Wichmann G., Nieber K., and Lehmann I. Induction of inflammatory signals in lung epithelial cells by volatile organic compounds. Toxicology in Vitro 22 2 (2008) 359-366
8. Herbarth O., and Rehwagen M. VOC - Untersuchungen zur indoor- und outdoor-exposition. Präsentation erster Ergebnisse einer umweltepidemiologischen Studie in Leipzig 1994-1997. Umweltmed Forsch Prax 3 (1998) 281-286
9. Karpus W.J., Lukacs N.W., Kennedy K.J., Smith W.S., Hurst S.D., and Barrett T.A. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 158 (1997) 4129-4136
10. Kuna P., Reddigari S.R., Rucinski D., Oppenheim J.J., and Kaplan A.P. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med 175 (1992) 489-493
11. Kusters E., and Lauwerys R. Biological monitoring of exposure to monochlorobenzene. Arch Occup Environ Health 62 (1990) 329-331
12. Lehmann I., Rehwagen M., Diez U., Seiffart A., Rolle-Kampczyk U., Richter M., et al. Enhanced in vivo IgE production and T cell polarization toward the type 2 phenotype in association with indoor exposure to VOC: results of the LARS study. Int J Hyg Environ Health 204 (2001) 211-221
13. McDermott C., Allshire A., van Pelt F.N., and Heffron J.J. Validation of a method for acute and subchronic exposure of cells in vitro to volatile organic solvents. Toxicol In Vitro 21 (2007) 116-124
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
15. NIOH/NIOSH. NIOH and NIOSH basis for an occupational health standard: chlorobenzene. MMWR Morb Mortal Wkly Rep 1994;43:148-9.
16. Oppenheim J.J., Zachariae C.O., Mukaida N., and Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 9 (1991) 617-648
17. Rahman I., and MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16 (2000) 534-554
18. Samet J.M., Marbury M.C., and Spengler J.D. Health effects and sources of indoor air pollution. Part II. Am Rev Respir Dis 137 (1988) 221-242
19. Von Burg R. Toxicology updates. Monochlorobenzene. J Appl Toxicol 1 (1981) 50-51
20. Wichmann G., Muhlenberg J., Fischader G., Kulla C., Rehwagen M., Herbarth O., et al. An experimental model for the determination of immunomodulating effects by volatile compounds. Toxicol In Vitro 19 (2005) 685-693
21. Willhite C.C., and Book S.A. Toxicology update. Monochlorobenzene. J Appl Toxicol 10 (1990) 307-310
22. Wu D., and Cederbaum A. Glutathione depletion in CYP2E1-expressing liver cells induces toxicity due to the activation of p38 mitogen-activated protein kinase and reduction of nuclear factor-kappaB DNA binding activity. Mol Pharmacol 66 (2004) 749-760
23. Yao T.C., Wu K.C., Chung H.T., Shaw C.K., Kuo M.L., Wu C.J., et al. MCP-1 gene regulatory region polymorphism in Chinese children with mild, moderate and near-fatal asthma. Allergy 59 (2004) 436-441
24. Yoshida M., Sunaga M., and Hara I. Urinary metabolites levels in workers exposed to chlorobenzene. Ind Health 24 (1986) 255-258